RxDoctor Payments Data

Francisco Munoz San Julian, MD

General Practice · Dade City, FLNPI 1578534392

Payments from drug & device makers

$957in general payments, 2019–2025

Across 47 payments — averaging $20.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$199
  • Novo Nordisk$124
  • AstraZeneca$114
  • GSK$99
  • BD$73
  • Novartis$51
  • plus $299 from 11 others

What the payments were for

  • Food & beverage$957100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$957 in reported general payments places this provider in the 75th percentile of 6,901 general practice providers in Florida.

See all general practice providers in Florida

Medicare billing

Part B allowed, 2024
$26,455
Medicare patients
89
Services billed
350

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$51,107
JanuviaSitagliptin Phosphate17$26,080
JardianceEmpagliflozin12$16,137
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$16,115
XareltoRivaroxaban18$15,007
OzempicSemaglutide12$14,931
Tresiba Flextouch U-100Insulin Degludec11$7,204
Spiriva RespimatTiotropium Bromide11$5,638
Naproxen13$2,793
Famotidine120$2,628
Azelastine Hcl86$2,398
Albuterol Sulfate HfaAlbuterol Sulfate88$2,389
Lantus SolostarInsulin Glargine,hum.Rec.Anlog11$2,382
Atorvastatin Calcium268$2,302
Rosuvastatin Calcium170$2,026

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$44$51,10749 claims
MerckJanuvia$25$26,08017 claims
GSKTrelegy Ellipta$99$16,11522 claims
Novo NordiskOzempic$124$14,93112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,901 general practice providers in Florida.

Other general practice in Dade City

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →